HAG:XETRHENSOLDT AG Analysis
Data as of 2026-06-17 - not real-time
€72.10
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hensoldt AG trades at €72.1, well below its DCF‑derived fair value of €75.8, suggesting a modest upside. The stock sits above its 200‑day SMA but below the 20‑ and 50‑day SMAs (≈€81 and €79), indicating a short‑term pullback. RSI at 37 points to mild oversold conditions, while the MACD histogram remains negative, reinforcing bearish momentum. Volume has been trending down, and the current price hovers just above the identified support level of €70.5. On the fundamentals side, revenue grew 25.6% YoY and free cash flow remains positive at €265 m, supporting the valuation case. However, operating margin is slightly negative and debt‑to‑equity is high at over 160%, flagging balance‑sheet pressure.
The forward PE of 31 is in line with the industry average, but the trailing PE of 83 is markedly elevated. No dividend is paid, so income‑focused investors have no yield cushion. The sector (aerospace & defense) benefits from stable government spending, yet geopolitical cycles can introduce volatility. The stock’s beta near zero and a 30‑day volatility of 58% reflect a mix of low market correlation but high idiosyncratic swings. The Fear & Greed Index reading of Extreme Greed suggests market optimism that may be premature. Overall, the price gap to DCF, solid top‑line growth, and defensive industry backdrop create a compelling case for a measured purchase, while short‑term technical signals advise caution.
The forward PE of 31 is in line with the industry average, but the trailing PE of 83 is markedly elevated. No dividend is paid, so income‑focused investors have no yield cushion. The sector (aerospace & defense) benefits from stable government spending, yet geopolitical cycles can introduce volatility. The stock’s beta near zero and a 30‑day volatility of 58% reflect a mix of low market correlation but high idiosyncratic swings. The Fear & Greed Index reading of Extreme Greed suggests market optimism that may be premature. Overall, the price gap to DCF, solid top‑line growth, and defensive industry backdrop create a compelling case for a measured purchase, while short‑term technical signals advise caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below 20‑day SMA and 50‑day SMA
- Bearish MACD histogram
- Decreasing volume near support
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth of 25.6% YoY
- DCF valuation gap indicating ~26% upside
- Forward PE aligning with industry
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Defensive aerospace & defense demand
- Positive free cash flow and cash reserves
- Long‑term undervaluation relative to DCF
Key Metrics & Analysis
Financial Health
Revenue Growth25.60%
Profit Margin3.91%
P/E Ratio82.9
ROE10.30%
ROA2.92%
Debt/Equity167.14
P/B Ratio8.7
Op. Cash Flow€498.0M
Free Cash Flow€265.5M
Industry P/E31.5
Technical Analysis
TrendNeutral
RSI37.2
Support€70.54
Resistance€91.72
MA 20€80.92
MA 50€78.99
MA 200€83.63
MACDBearish
VolumeDecreasing
Fear & Greed Index91.95
Valuation
Fair Value€75.82
Target Price€90.97
Upside/Downside26.17%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta-0.04
Volatility58.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.